Daito Pharmaceutical Co.,Ltd.

Symbol: 4577.T

JPX

2540

JPY

Market price today

  • 12.0844

    P/E Ratio

  • -0.4769

    PEG Ratio

  • 39.73B

    MRK Cap

  • 0.02%

    DIV Yield

Daito Pharmaceutical Co.,Ltd. (4577-T) Financial Statements

On the chart you can see the default numbers in dynamics for Daito Pharmaceutical Co.,Ltd. (4577.T). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Daito Pharmaceutical Co.,Ltd., we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

0360743813372.9
3084.1
1819.4
1711.4
1617.3
1351.1
1918.7
2513
4149.1
1572.2
1757.7
2611.4
1162.9

balance-sheet.row.short-term-investments

0-205-206-294.2
-249.5
-240
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

010670105858382
9065.5
9394.7
9497.5
9901.9
9275
10322.6
10064.7
9610.1
8767.5
8366.2
7149.8
7003

balance-sheet.row.inventory

0182381682015751.7
12130.7
10059.1
9308.6
8493
6984
5352.3
4436.5
4018
3418.7
3485.7
2909.7
3098.5

balance-sheet.row.other-current-assets

0814861234923.3
6574.8
3087.3
4538.8
4333.5
4470.7
4123.1
3046.2
755.1
427.2
350.5
213.9
167.5

balance-sheet.row.total-current-assets

0406633790932429.9
30855.2
24360.5
25056.3
24345.7
22080.8
21716.8
20060.4
18532.2
14185.6
13960.1
12884.8
11431.9

balance-sheet.row.property-plant-equipment-net

0258372311621372
19399.6
18732.1
18654.2
17878.4
17446.9
16440.6
13445.1
12992
13329.9
12722.8
12533
12750.1

balance-sheet.row.goodwill

0000
0
0
0
0
0
0
0
0
0
0
0
2

balance-sheet.row.intangible-assets

0377386332.7
299.4
306.5
330
321.9
400.1
521.9
588.2
558.3
483.6
285.6
165.4
155.3

balance-sheet.row.goodwill-and-intangible-assets

0377386332.7
299.4
306.5
330
321.9
400.1
521.9
588.2
558.3
483.6
285.6
165.4
157.3

balance-sheet.row.long-term-investments

0316929583096
3393
3020
2877.5
2829
3087.8
3358.5
2332
2326.2
1429.7
1628.5
1736.3
1609.2

balance-sheet.row.tax-assets

0504570508
302.3
329.8
32.9
31
30.9
32.8
52.1
34.4
67.2
77.6
16.4
16.9

balance-sheet.row.other-non-current-assets

00-10.7
0.3
0.2
245.2
301.8
293.7
234.7
216.9
319.1
413.5
397.4
379.8
388.2

balance-sheet.row.total-non-current-assets

0298872702925309.5
23394.6
22388.5
22139.8
21362.2
21259.4
20588.4
16634.3
16230.1
15724
15111.9
14830.9
14921.5

balance-sheet.row.other-assets

0210
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0705526493957739.4
54249.7
46749.1
47196.1
45707.9
43340.2
42305.2
36694.7
34762.3
29909.5
29072
27715.8
26353.4

balance-sheet.row.account-payables

0443544934359.6
4330.4
4086.2
3620.6
3587
3644.3
4176.8
3445.4
3185.9
3458
3530.8
3041.5
3248.1

balance-sheet.row.short-term-debt

0151312001375.1
1782.3
2319.1
4036.3
5937.8
8566.2
8567.5
9094
8948.8
6184.4
6031.5
6578.6
5542.7

balance-sheet.row.tax-payables

055914021098.5
1302.7
351.9
729.3
1022.1
366.9
821.8
666
293
609.8
531.8
199
358.9

balance-sheet.row.long-term-debt-total

0344522472018.9
1582.7
3098.1
4027.9
3712
3692.2
3492
4474.8
5346.3
5547
6016
5946.7
7988.5

Deferred Revenue Non Current

0507755764.3
568.2
506.1
514.4
484.7
455.4
195.9
227.4
207.8
258.4
333.9
391.9
452.8

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0410138873399.9
4410
2761.9
5297.3
2349
812.6
614.1
639.4
64
1457.3
1362.1
993.8
1108.6

balance-sheet.row.total-non-current-liabilities

0415331992963.2
2327
3781.9
5017
4659
4713.9
4464.6
5203.5
6063.8
6178
6754.5
6766.5
8849.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

09201.5
4.5
9.1
17.5
32.4
65.1
286.2
536.2
904.8
1205.9
1550.2
1662.4
1790.3

balance-sheet.row.total-liab

0195811726815822
17381.4
15399.7
18700.6
19894
19779.9
20450.5
20070.1
19688.6
18392.9
18704.1
18071.7
19638.4

balance-sheet.row.preferred-stock

049141462730
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0718670316271.2
5370.2
4367.8
4367.8
4367.8
4367.8
4367.8
3120.3
3120.3
2565.1
2565.1
2565.1
1437.5

balance-sheet.row.retained-earnings

0350063233828331.6
24742.9
21301.6
18239.1
15610.1
13329.3
11138.3
9342.8
7828
6310.1
5100.1
4288.6
3644

balance-sheet.row.accumulated-other-comprehensive-income-loss

015311031872.4
1153.1
1031.9
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0-42192-393696143.7
5243
4240.7
5453.4
5388.2
5460.6
5954.4
3814.5
3802.1
2641.5
2702.7
2790.3
1633.4

balance-sheet.row.total-stockholders-equity

0506724730441619
36509.2
30942
28060.3
25366.1
23157.6
21460.5
16277.6
14750.4
11516.7
10367.8
9644
6714.9

balance-sheet.row.total-liabilities-and-stockholders-equity

0705526493957739.4
54249.7
46749.1
47196.1
45707.9
43340.2
42305.2
36694.7
34762.3
29909.5
29072
27715.8
26353.4

balance-sheet.row.minority-interest

0299367298.4
359.1
407.3
435.2
447.7
402.7
394.1
347
323.3
0
0
0
0

balance-sheet.row.total-equity

0509714767141917.4
36868.4
31349.4
28495.6
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0296427522801.8
3143.5
2780
2877.5
2829
3087.8
3358.5
2332
2326.2
1429.7
1628.5
1736.3
1609.2

balance-sheet.row.total-debt

0495834473394
3365
5417.2
8064.2
9649.8
12258.4
12059.5
13568.7
14295.1
11731.4
12047.6
12525.3
13531.2

balance-sheet.row.net-debt

01351-93421.1
280.9
3597.8
6352.8
8032.4
10907.3
10140.8
11055.7
10146
10159.2
10289.9
9913.8
12368.3

Cash Flow Statement

The financial landscape of Daito Pharmaceutical Co.,Ltd. has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

0507667205873.9
5595.2
4618.8
4263.1
3885.2
3426.1
3372.8
2869.4
2608
2454.7
1678.1
1268
1169.2

cash-flows.row.depreciation-and-amortization

0387033133154.3
2950.5
2852.5
2853.2
2818.2
2643.2
2439.9
2444.8
2569.4
2269.2
2093
1952.9
1745.2

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-2326-4399-1582.4
-4220.2
538.4
392
-2127.7
-1824
-817.1
-1911.5
-1283.7
-678.4
-793.4
-637.2
-1998.6

cash-flows.row.account-receivables

0-1502-32992723
-3369
947
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-1413-1041-3609.2
-2075.5
-751
-815.1
-1508.8
-1631.7
-915.8
-418.5
-599.3
54.3
-576
188.8
231.6

cash-flows.row.account-payables

053822-765.1
1229.3
335
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

051-8169
-5
7.3
1207.1
-618.9
-192.3
98.7
-1493
-684.4
-732.7
-217.5
-825.9
-2230.2

cash-flows.row.other-non-cash-items

0-2465-1264-2263.3
-19.2
-1121.5
-2042.8
494
-1296.4
-1256.3
-658.1
-1352.3
-702.6
-148.5
-416.5
105.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-5556-4733-6349.6
-2773.3
-3662.8
-3873.7
-2992.2
-3948.6
-4919.1
-2334.9
-1859
-2936.1
-3066.7
-1250.3
-4656.6

cash-flows.row.acquisitions-net

00680
-42.1
0
0
0
0
28.9
0.6
62
21.4
0.7
1.2
0.5

cash-flows.row.purchases-of-investments

00-680
-77.8
-212.4
-12.5
0
-49
-37.4
-791.5
-665
-11
-81.9
-93.6
-326.6

cash-flows.row.sales-maturities-of-investments

002565
175.3
0
0
0
7.7
384.7
1123.2
183.8
2
1.4
7.1
19.2

cash-flows.row.other-investing-activites

0-107720.3
36.5
7.7
53.1
-19.7
-25.3
-51.6
-160.1
41.2
-255.4
-188.6
62.6
-69.5

cash-flows.row.net-cash-used-for-investing-activites

0-5566-4400-6324.3
-2681.4
-3867.4
-3833.1
-3011.8
-4015.2
-4594.5
-2162.7
-2237
-3179.1
-3335.2
-1273.2
-5033

cash-flows.row.debt-repayment

0-1638-1444-1712.4
-1851.9
-2038.5
-2265.3
-2335.5
-2622.3
-2632.1
-2768.7
-2905.2
-2712.9
-2637.4
-2777.5
-2108.2

cash-flows.row.common-stock-issued

030815141798.5
2000.5
-408.4
0
97.8
72.9
2475.4
999.3
1098.9
2547.7
2467.3
2228.4
2120.8

cash-flows.row.common-stock-repurchased

0-1161499-0.3
-0.2
-0.4
-1
-0.7
-2.3
-8.3
-0.1
0
-0.1
-0.2
1303.7
2570.7

cash-flows.row.dividends-paid

0-931-660-658.1
-502.1
-450.7
-412.6
-375.3
-374.6
-466.2
-296
-267.8
-178.8
-178.8
-107.8
-40.4

cash-flows.row.other-financing-activites

02993801997
3.2
0
1135.3
835.9
3452.6
1134
0
3764.5
0
0
0
1630.4

cash-flows.row.net-cash-used-provided-by-financing-activities

06169891424.8
-350.5
-2898.1
-1543.6
-1777.7
526.3
502.9
-2065.4
1690.5
-344.1
-349.1
646.8
4173.3

cash-flows.row.effect-of-forex-changes-on-cash

020485.8
-9.7
-14.6
5.4
-14
-27.6
-14.6
70.5
131.5
1.3
-0.5
-0.4
-0.2

cash-flows.row.net-change-in-cash

0-7741009288.8
1264.7
108
94.1
266.2
-567.6
-366.9
-1412.9
2126.4
-179
-855.7
1540.5
161

cash-flows.row.cash-at-end-of-period

0360743813372.9
3084.1
1819.4
1711.4
1617.3
1351.1
1918.7
2285.7
3698.6
1572.2
1751.2
2606.9
1066.4

cash-flows.row.cash-at-beginning-of-period

0438133723084.1
1819.4
1711.4
1617.3
1351.1
1918.7
2285.7
3698.6
1572.2
1751.2
2606.9
1066.4
905.4

cash-flows.row.operating-cash-flow

0415543705182.5
4306.3
6888.2
5465.3
5069.7
2948.9
3739.3
2744.7
2541.4
3342.9
2829.1
2167.2
1020.9

cash-flows.row.capital-expenditure

0-5556-4733-6349.6
-2773.3
-3662.8
-3873.7
-2992.2
-3948.6
-4919.1
-2334.9
-1859
-2936.1
-3066.7
-1250.3
-4656.6

cash-flows.row.free-cash-flow

0-1401-363-1167
1533
3225.4
1591.7
2077.6
-999.8
-1179.8
409.8
682.4
406.8
-237.7
916.9
-3635.7

Income Statement Row

Daito Pharmaceutical Co.,Ltd.'s revenue saw a change of NaN% compared with the previous period. The gross profit of 4577.T is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

0451014346448709.2
44997.1
41135.1
39883.6
37973.4
36331.2
34062.4
31202.2
28959.2
27149.4
25218.4
22679.5
21460.7

income-statement-row.row.cost-of-revenue

0347703200537917.3
35512.6
32463.3
31765.4
30232.3
29104.4
26990.4
25213.1
23031.1
21491.1
20518.2
18982.9
17937.1

income-statement-row.row.gross-profit

0103311145910791.9
9484.5
8671.7
8118.2
7741.1
7226.8
7072
5989.1
5928.1
5658.3
4700.2
3696.6
3523.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

033728.4
28.8
28.3
25.8
47.9
42.7
40
30
25.9
97.6
80.4
23
52

income-statement-row.row.operating-expenses

0512349054883.1
4127.2
4124.4
3957.1
3908.9
3670.9
3553
3050.2
3249.2
3031.7
2741.4
2245.7
2185.1

income-statement-row.row.cost-and-expenses

0398933691042800.3
39639.8
36587.7
35722.5
34141.2
32775.3
30543.4
28263.3
26280.3
24522.9
23259.5
21228.6
20122.2

income-statement-row.row.interest-income

045460.4
0.5
1.4
0.7
0.7
0.7
12.8
10.4
0.1
0.1
0.1
0.2
7.6

income-statement-row.row.interest-expense

01297.8
11.9
20.9
24.1
28.6
39.6
58.4
87.1
126.3
158.1
182.3
219.9
210.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-135152-43
233
72
101.9
53
-129.8
-146.1
-69.5
-70.9
-171.9
-280.8
-182.9
-169.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

033728.4
28.8
28.3
25.8
47.9
42.7
40
30
25.9
97.6
80.4
23
52

income-statement-row.row.total-operating-expenses

0-135152-43
233
72
101.9
53
-129.8
-146.1
-69.5
-70.9
-171.9
-280.8
-182.9
-169.3

income-statement-row.row.interest-expense

01297.8
11.9
20.9
24.1
28.6
39.6
58.4
87.1
126.3
158.1
182.3
219.9
210.1

income-statement-row.row.depreciation-and-amortization

0387033133154.3
2950.5
2852.5
2853.2
2818.2
2643.2
2439.9
2444.8
2569.4
2269.2
2093
1952.9
1745.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0520765535908.8
5357.3
4547.3
4161.2
3832.2
3555.8
3519
2938.9
2678.9
2626.6
1958.9
1450.9
1338.5

income-statement-row.row.income-before-tax

0507667205873.9
5595.2
4618.8
4263.1
3885.2
3426.1
3372.8
2869.4
2608
2454.7
1678.1
1268
1169.2

income-statement-row.row.income-tax-expense

0154920921716.9
1670.4
1122.4
1250.6
1258.2
878.7
1136.4
1064.7
821.9
1065.5
687.4
515.6
476.2

income-statement-row.row.net-income

0360046684246
3944.7
3513
3041.9
2656.3
2566.4
2246.1
1811.4
1786.6
1389.1
990.6
752.4
693

Frequently Asked Question

What is Daito Pharmaceutical Co.,Ltd. (4577.T) total assets?

Daito Pharmaceutical Co.,Ltd. (4577.T) total assets is 70552000000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.214.

What is company free cash flow?

The free cash flow is 346.005.

What is enterprise net profit margin?

The net profit margin is 0.073.

What is firm total revenue?

The total revenue is 0.093.

What is Daito Pharmaceutical Co.,Ltd. (4577.T) net profit (net income)?

The net profit (net income) is 3600000000.000.

What is firm total debt?

The total debt is 4958000000.000.

What is operating expences number?

The operating expences are 5123000000.000.

What is company cash figure?

Enretprise cash is 0.000.